Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
Instructions to Safeguard Your Speculations In the midst of Changing Disc Rates - 2Bestselling author Colleen Hoover reveals cancer journey
- 3Cocaine, caffeine, painkillers consumed by sharks in Bahamas, study finds
- 4Lockheed Martin opens new hypersonic weapons facility
- 5Higher cost, worse coverage: Affordable Care Act enrollees say expiring subsidies will hit them hard
- Most loved Occasion Dish: What Makes Your Merry Table?
- Atorvastatin recall may affect hundreds of thousands of patients – and reflects FDA’s troubles inspecting medicines manufactured overseas
- The most effective method to Go Down Abundance through Ages with Disc Rates
- You finally got a doctor's appointment. Here's how to get the most out of it
- The most exciting exoplanet discoveries of 2025
- How Would You Like to Deal with Your Funds?
- The most effective method to Boost Eco-friendliness in Your Volvo XC40
- 'Stranger Things' star debunks claims of 'unseen footage' from Season 5, Volume 2 as backlash intensifies ahead of the series finale
- Trump says Venezuela will start 'turning over' oil to the U.S. Is that the reason he toppled Maduro — or is it something else?
